THE LACK OF LONG‐TERM DETRIMENTAL EFFECTS ON LIVER ALLOGRAFTS CAUSED BY DONOR‐SPECIFIC ANTI‐HLA ANTIBODIES

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Transplantation

• Publication date

  1993-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199305000-00023PMID 8497883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2

  1992cited by this paper
• Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.

  1991cited by this paper
• Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys

  1989cited by this paper
• Hyperacute rejection in liver transplantation: a case report.

  1989cited by this paper
• Development of anti-HLA antibodies following renal transplantation--their characteristics and natural history.

  1982cited by this paper
• Successful liver transplantation from crossmatch-positive donors.

  1981cited by this paper
• Fifteen years of clinical liver transplantation.

  1979cited by this paper

• Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation

  2021cites this paper
• De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-Analysis

  2020cites this paper
• Influence of Preformed Antibodies in Liver Transplantation

  2020cites this paper
• Diagnostics and treatment of a severe humoral rejection after liver transplantation: donor-specific antibodies as a still underestimated cause of graft failure

  2016cites this paper
• Donor‐Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients

  2016cites this paper
• Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation

  2015cites this paper
• Detecting the humoral alloimmune response: we need more than serum antibody screening.

  2015cites this paper
• HLA incompatible combined liver-kidney transplantation: dynamics of antibody modulation revealed by a novel approach to HLA antibody characterisation.

  2014cites this paper
• Influence of preformed donor-specific antibodies and C4d on early liver allograft function

  2013cites this paper
• Blocking porcine sialoadhesin improves extracorporeal porcine liver xenoperfusion with human blood

  2013cites this paper
• Liver transplantation with a strongly positive crossmatch: Case study and literature review

  2013cites this paper
• Does a positive pretransplant crossmatch affect long-term outcome in liver transplantation?

  2011cites this paper
• 69 Pathology of Liver Transplantation

  2010cites this paper
• UCLA liver transplantation: analysis of immunological factors affecting outcome.

  2008cites this paper
• Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility

  2008cites this paper
• Anti‐HLA alloantibodies in pediatric solid organ transplantation

  2006cites this paper
• Clinical importance of non-HLA antibodies in solid organ transplantation

  2006cites this paper
• Mechanisms of liver allograft rejections

  2005cites this paper
• Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre.

  2005cites this paper
• Human Leukocyte Antigen Antibodies for Monitoring Transplant Patients

  2005cites this paper
• Mechanisms of liver allograft rejections

  2005cites this paper
• Untersuchung von nierentransplantierten Patienten unter Berücksichtigung der HLA-Kompatibilität und der Dynamik der HLA-Antikörperbildung

  2005influential citation
• Incidence and role of antibody in graft injury: How can it best be monitored?

  2004cites this paper
• Are preformed antibodies to biliary epithelial cells of clinical importance in liver transplantation?

  2003cites this paper
• Immunological reactions in liver graft perireperfusion in living donor liver transplantation--change of expression of adhesion molecules, deposition of immunoglobulins and cytokine level.

  2003cites this paper
• Prolonged function of extracorporeal hDAF transgenic pig livers perfused with human blood1

  2002cites this paper
• Is presensitization relevant to liver transplantation outcome?

  2002cites this paper
• Specialized transfusion support for solid organ transplantation

  2002cites this paper
• Susceptibility of Liver Allografts to High or Low Concentrations of Preformed Antibodies as Measured by Flow Cytometry

  2001cites this paper
• A large, single center investigation of the immunogenetic factors affecting liver transplantation.

  2000cites this paper
• Immunology of acute and chronic hepatic allograft rejection.

  1999cites this paper
• The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection.

  1998cites this paper
• Transfusion Support in Solid-Organ Transplantation

  1998cites this paper
• Significance of preformed anti-donor antibodies in liver transplantation.

  1997cites this paper
• A positive crossmatch in liver transplantation--no effect or inappropriate analysis? A prospective study.

  1997cites this paper
• Cross-matching in liver transplantation.

  1997cites this paper
• Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation.

  1996cites this paper
• Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch.

  1996cites this paper
• Reduced size liver transplantation, split liver transplantation, and living related liver transplantation in relation to the donor organ shortage

  1995cites this paper
• Liver transplantation and the lymphocyte crossmatch

  1995cites this paper
• Immunoglobulin g lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance

  1995cites this paper
• Antibody removal therapy in transplantation

  1995cites this paper
• Immunopathology of porcine livers perfused with blood of humans with fulminant hepatic failure.

  1995cites this paper
• IgG DONOR‐SPECIFIC CROSSMATCHES ARE NOT ASSOCIATED WITH GRAFT REJECTION OR POOR GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: AN ASSESSMENT BY CYTOTOXICITY AND FLOW CYTOMETRY

  1995cites this paper
• SPECIFIC INHIBITION OF HLA CLASS I AND II ANTIBODIES BY SOLUBLE ANTIGENS—A METHOD FOR THE IDENTIFICATION OF ANTIBODY SPECIFICITY IN SERA FROM ALLOIMMUNIZED INDIVIDUALS

  1994cites this paper
• HLA COMPATIBILITY AND LIVER TRANSPLANT OUTCOME Improved Patient Survival by HLA and Cross‐Matching

  1994cites this paper
• MECHANISMS OF INJURY IN PORCINE LIVERS PERFUSED WITH BLOOD OF PATIENTS WITH FULMINANT HEPATIC FAILURE

  1994cites this paper